CVE-2026-19532: Havelsan Inc Liman Mys

Medium severity, CVSS 5.3. EPSS: 0.3% chance of exploitation in the next 30 days.

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: from 2.3.2 before 2.3.4-1124.

Affected products

• Havelsan Inc Liman Mys: from 2.3.2, before 2.3.4-1124 (fixed in 2.3.4-1124)

Published 2026-09-24. Last modified 2026-09-24.